Yukari Kobayashi

6PUBLICATIONS
22CO-AUTHORS
Predictive and prognostic markersMolecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 17, 2026
High Sensitivity ctDNA Analysis Using a Novel Panel and NOIR-SS Technology for Monitoring Advanced Urothelial Carcinoma.

|Nov 26, 2025
NeoPAIR-T: Functional Mapping of Neoantigen-TCR Pairs Using a CRISPR-Engineered Jurkat Reporter System.

Koji Nagaoka, Yukari Kobayashi, Kazuhiro Kakimi

|May 16, 2025
Phase II Study (NO LIMIT, WJOG13320G) of First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability-High Advanced Gastric or Esophagogastric Junction Cancer.

Hisato Kawakami, Shigenori Kadowaki, Akitaka Makiyama

|Dec 09, 2023
Alterations in Intratumoral Immune Response before and during Early-On Nivolumab Treatment for Unresectable Advanced or Recurrent Gastric Cancer.

Yasuyoshi Sato, Hiroharu Yamashita, Yukari Kobayashi

|Jan 11, 2022
Identification of Neoantigens in Two Murine Gastric Cancer Cell Lines Leading to the Neoantigen-Based Immunotherapy.

Koji Nagaoka, Changbo Sun, Yukari Kobayashi

|Nov 13, 2021
Neoantigen Dendritic Cell Vaccination Combined with Anti-CD38 and CpG Elicits Anti-Tumor Immunity against the Immune Checkpoint Therapy-Resistant Murine Lung Cancer Cell Line LLC1.

Changbo Sun, Koji Nagaoka, Yukari Kobayashi

Pageof 1

Frequent Collaborators

3 joint publications

Koji Nagaoka

3 joint publications

Kazuhiro Kakimi

2 joint publications

Hidewaki Nakagawa

2 joint publications

Sachiyo Nomura